drugset / Trial / NCT01169753

Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients

NCT01169753

RandomizedCrossoverTriple-blindTreatment

Summary

The goal of this clinical research study is to learn if Nuvigil (armodafinil) can help to control fatigue in patients with CML. The safety of this drug will also be studied.

Timeline

Start
2011-05
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Armodafinil Small molecule 50 mg Oral